Skip to main content
. 2010 Jun 10;14(3):R108. doi: 10.1186/cc9057

Table 2.

Severity of illness scores, laboratory tests and use of catecholamines during ICU stay

New-onset AF, no septic shock
(n = 26)
New-onset AF and septic shock
(n = 23)
Maintained SR and septic shock
(n = 27)
P1-value P2-value
Severity of illness scores
SOFA max 8.5 (4-14) 12 (7-17) 9 (5-18) < 0.01 0.01
SAPS II 34 (7-60) 31 (15-63) 30 (12-65) 0.87 0.12
Max. CRP level (mg/dl) 249 (14-339) 288 (72-483) 273 (23-412) 0.04 0.28
Use of catecholamines
Noradrenaline max.
(μg/kg/min)
0.18 (0.00-1.00) 0.50 (0.15-2.00) 0.30 (0.15-1.40 < 0.01 0.13
Noradrenaline at AF (μg/kg/min) 0.05 (0.00-0.40) 0.40 (0.03-1.10) - < 0.01
Dobutamine
(number of patients)
2 10 6 < 0.01 0.14
Serum electrolytes at AF
K+ (mval/l) 4.4 (3.9-5.0) 4.4 (3.8-5.6) - 0.63
Na+ (mval/l) 137 (130-163) 140 (132-161) - 0.42
Ca++ (mval/l) 1.2 (1.1-1.6) 1.1 (0.7-1.3) - 0.10

Data are given as median (range in parenthesis) or number. P1-value, patients with new-onset atrial fibrillation (AF) without septic shock vs. septic shock patients with new-onset AF; P2-value, septic shock patients with new-onset AF vs. septic shock patients with maintained sinus rhythm (SR).

SOFA max, maximum of the daily calculated sequential organ failure assessment score; SAPS II, simplified acute physiologic score II on admission; Max. CRP level, maximal C-reactive protein level during ICU stay; noradrenaline max, maximal noradrenaline dose during ICU stay; noradrenaline at AF, noradrenaline dose when AF occurred; serum electrolytes at AF, serum electrolyte concentrations when AF occurred.